Statistics for Assembly Biosciences (id:8418 ASMB)

Valuation metrics

Market cap

108.37M

Enterprise value

3.57M

Trailing P/E (ttm)

-1.12

Forward P/E

-2.46

PEG ratio

-2.46

Price/Sales (ttm)

5.05

Price/Book (mrq)

2.27

Enterprise Value/Revenue

0.17

Enterprise Value/EBITDA

-0.07

Overview

Shares outstanding

6.35M

Float

3.83M

Shares short

16.42K

% Held by insiders

0.32%

% Held by institutions

0.19%

Average volume (10 days)

29.24K

Average volume (90 days)

Price summary

52-Week low

8.28

52-Week high

19.93

52-Week change

42.55%

Beta

0.59

50-Day moving average

16.73

200-Day moving average

14.55

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

February 12th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-212.33%

Operating margin

-143.01%

Operational effectiveness

Return on assets

-34.72%

Return on equity

-101.78%

Income statement

Revenue (ttm)

4.12

Revenue per share (ttm)

4.12

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-50,267,000.00

Net income to common (ttm)

-45,611,000.00

Diluted EPS (ttm)

-8.69

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

109.22M

Total cash per share (mrq)

17.21

Total debt (mrq)

1.75M

Total Debt/Equity (mrq)

5.03

Current ratio (mrq)

273.60%

Book value per share (mrq)

7.50

Cash flow

Cash flow statement

24.33M

Levered free cash flow (LFCF)

5.50M